leukemia - Cleveland Clinic

22-CNR-3001718-CQD-Hero-650x450S-WOG 1318 Phase 2 Trial

July 28, 2022/Cancer/Research

Phase 2 Study Shows Promise for Treating Older Adults with Ph-Negative B-ALL

Blinatumomab followed by POMP maintenance shows effectiveness for newly diagnosed patients

April 27, 2022/Cancer/Blood Cancers

Hairy Cell Leukemia Complicated by Severe COVID-19: A Case Study

Novel three-drug regimen used to manage life-threatening developments

August 31, 2020/Basic & Translational Science

Succession of Molecular Lesions Critical to Leukemia Disease Development

Mutational pattern in MDS is not random, study finds

June 22, 2020/Cancer/News & Insight

Learning from Leukemia

A Cleveland Clinic oncologist’s book reflects on patients’ and physicians’ shared journeys

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

December 1, 2018/Cancer/Research

Blinatumomab Trial: 66 Percent of Patients Achieve Remission from Acute Lymphoblastic Leukemia

Lower toxicity than conventional chemo

November 14, 2018/Cancer/Research

How Nucleophosmin Mutation Causes Acute Myeloid Leukemia

Groundbreaking study paves way for targeted therapy

April 12, 2018/Cancer/Research

Thyroid Cancer Treatment with Radioactive Iodine Increases Risk of Leukemia

Study shows risk of overtreating patients

March 28, 2016/Cancer/Genomics

A ‘Paradigm Shift’ in Conception of Aplastic Anemia

Gene mutations discovered in some patients may lead to malignancy

Tag: leukemia